Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice

Journal of Immunology

Volumn 192, Issue 1, 2014, Pages 394-406

  Vergadi, Eleni ^a   Vaporidi, Katerina ^a   Theodorakis, Emmanuel E ^a   Doxaki, Christina ^a   Lagoudaki, Eleni ^a   Ieronymaki, Eleftheria ^a   Alexaki, Vassilia I ^a   Helms, Mike ^b   Kondili, Eumorfia ^a   Soennichsen, Birte ^b   Stathopoulos, Efstathios N ^a   Margioris, Andrew N ^a   Georgopoulos, Dimitrios ^a   Tsatsanis, Christos ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b Cenix Bioscience   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; HYDROCHLORIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MICRORNA 146A; PROTEIN KINASE B BETA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE OVEREXPRESSION; GENE SILENCING; INJURY SEVERITY; LUNG ALVEOLUS MACROPHAGE; LUNG COMPLIANCE; LUNG LAVAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN INDUCTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 84891079308     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300959     Document Type: Article

References (64)

1. Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342: 1334-1349.
2. Matute-Bello, G., C. W. Frevert, and T. R. Martin. 2008. Animal models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L379-L399.
3. Frank, J. A., J. F. Pittet, H. Lee, M. Godzich, and M. A. Matthay. 2003. High tidal volume ventilation induces NOS2 and impairs cAMP-dependent air space fluid clearance. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L791-L798.
4. Frank, J. A., C. M. Wray, D. F. McAuley, R. Schwendener, and M. A. Matthay. 2006. Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L1191-L1198.
5. Eyal, F. G., C. R. Hamm, and J. C. Parker. 2007. Reduction in alveolar macrophages attenuates acute ventilator induced lung injury in rats. Intensive Care Med. 33: 1212-1218.
6. Dolinay, T., M. Szilasi, M. Liu, and A. M. Choi. 2004. Inhaled carbon monoxide confers antiinflammatory effects against ventilator-induced lung injury. Am. J. Respir. Crit. Care Med. 170: 613-620.
7. Dreymueller, D., C. Martin, T. Kogel, J. Pruessmeyer, F. M. Hess, K. Horiuchi, S. Uhlig, and A. Ludwig. 2012. Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide. EMBO Mol. Med. 4: 412-423.
8. Johnston, L. K., C. R. Rims, S. E. Gill, J. K. McGuire, and A. M. Manicone. 2012. Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury. Am. J. Respir. Cell Mol. Biol. 47: 417-426.
9. Gea-Sorlí, S., R. Guillamat, A. Serrano-Mollar, and D. Closa. 2011. Activation of lung macrophage subpopulations in experimental acute pancreatitis. J. Pathol. 223: 417-424.
10. Janssen, W. J., L. Barthel, A. Muldrow, R. E. Oberley-Deegan, M. T. Kearns, C. Jakubzick, and P. M. Henson. 2011. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 184: 547-560.
11. Dhaliwal, K., E. Scholefield, D. Ferenbach, M. Gibbons, R. Duffin, D. A. Dorward, A. C. Morris, D. Humphries, A. MacKinnon, T. S. Wilkinson, et al. 2012. Monocytes control second-phase neutrophil emigration in established lipopolysaccharide-induced murine lung injury. Am. J. Respir. Crit. Care Med. 186: 514-524.
12. Imai, Y., K. Kuba, G. G. Neely, R. Yaghubian-Malhami, T. Perkmann, G. van Loo, M. Ermolaeva, R. Veldhuizen, Y. H. Leung, H. Wang, et al. 2008. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133: 235-249.
13. Kudoh, I., H. Miyazaki, M. Ohara, J. Fukushima, T. Tazawa, and H. Yamada. 2001. Activation of alveolar macrophages in acid-injured lung in rats: different effects of pentoxifylline on tumor necrosis factor-alpha and nitric oxide production. Crit. Care Med. 29: 1621-1625.
14. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
15. Jian, M. Y., T. Koizumi, and K. Kubo. 2005. Effects of nitric oxide synthase inhibitor on acid aspiration-induced lung injury in rats. Pulm. Pharmacol. Ther. 18: 33-39.
16. Peng, X., R. E. Abdulnour, S. Sammani, S. F. Ma, E. J. Han, E. J. Hasan, R. Tuder, J. G. Garcia, and P. M. Hassoun. 2005. Inducible nitric oxide synthase contributes to ventilator-induced lung injury. Am. J. Respir. Crit. Care Med. 172: 470-479.
17. Liu, R., Y. Hotta, A. R. Graveline, O. V. Evgenov, E. S. Buys, K. D. Bloch, F. Ichinose, and W. M. Zapol. 2007. Congenital NOS2 deficiency prevents impairment of hypoxic pulmonary vasoconstriction in murine ventilator-induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L1300-L1305.
18. Farley, K. S., L. F. Wang, H. M. Razavi, C. Law, M. Rohan, D. G. McCormack, and S. Mehta. 2006. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L1164-L1172.
19. Herold, S., K. Mayer, and J. Lohmeyer. 2011. Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front. Immunol. 2: 65.
20. Ionescu, L., R. N. Byrne, T. van Haaften, A. Vadivel, R. S. Alphonse, G. J. Rey-Parra, G. Weissmann, A. Hall, F. Eaton, and B. Thébaud. 2012. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am. J. Physiol. Lung Cell. Mol. Physiol. 303: L967-L977.
21. Gordon, S., and F. O. Martinez. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
22. Arranz, A., C. Doxaki, E. Vergadi, Y. Martinez de la Torre, K. Vaporidi, E. D. Lagoudaki, E. Ieronymaki, A. Androulidaki, M. Venihaki, A. N. Margioris, et al. 2012. Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc. Natl. Acad. Sci. USA 109: 9517-9522.
23. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Tolllike receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6: 644-658.
24. Spence, S., A. Fitzsimons, C. R. Boyd, J. Kessler, D. Fitzgerald, J. Elliott, J. N. Gabhann, S. Smith, A. Sica, E. Hams, et al. 2013. Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity 38: 66-78.
25. Androulidaki, A., D. Iliopoulos, A. Arranz, C. Doxaki, S. Schworer, V. Zacharioudaki, A. N. Margioris, P. N. Tsichlis, and C. Tsatsanis. 2009. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31: 220-231.
26. Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736.
27. Iliopoulos, D., C. Polytarchou, M. Hatziapostolou, F. Kottakis, I. G. Maroulakou, K. Struhl, and P. N. Tsichlis. 2009. MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci. Signal. 2: ra62.
28. Lee, Y. G., J. Lee, S. E. Byeon, D. S. Yoo, M. H. Kim, S. Y. Lee, and J. Y. Cho. 2011. Functional role of Akt in macrophage-mediated innate immunity. Front. Biosci. (Landmark Ed.) 16: 517-530.
29. Fukao, T., and S. Koyasu. 2003. PI3K and negative regulation of TLR signaling. Trends Immunol. 24: 358-363.
30. Gray, M. J., M. Poljakovic, D. Kepka-Lenhart, and S. M. Morris, Jr. 2005. Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. Gene 353: 98-106.
31. He, M., Z. Xu, T. Ding, D. M. Kuang, and L. Zheng. 2009. MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta. Cell. Mol. Immunol. 6: 343-352.
32. Prakash, A., K. R. Mesa, K. Wilhelmsen, F. Xu, J. M. Dodd-o, and J. Hellman. 2012. Alveolar macrophages and Toll-like receptor 4 mediate ventilated lung ischemia reperfusion injury in mice. Anesthesiology 117: 822-835.
33. Reino, D. C., V. Pisarenko, D. Palange, D. Doucet, R. P. Bonitz, Q. Lu, I. Colorado, S. U. Sheth, B. Chandler, K. B. Kannan, et al. 2011. Trauma hemorrhagic shock-induced lung injury involves a gut-lymph-induced TLR4 pathway in mice. PLoS ONE 6: e14829.
34. Williams, A. E., M. M. Perry, S. A. Moschos, H. M. Larner-Svensson, and M. A. Lindsay. 2008. Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem. Soc. Trans. 36: 1211-1215.
35. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaBdependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486.
36. Vaporidi, K., R. C. Francis, K. D. Bloch, and W. M. Zapol. 2010. Nitric oxide synthase 3 contributes to ventilator-induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 299: L150-L159.
37. Reinhard, C., G. Eder, H. Fuchs, A. Ziesenis, J. Heyder, and H. Schulz. 2002. Inbred strain variation in lung function. Mamm. Genome: 13: 429-437.
38. Kimura, I., Y. Moritani, and Y. Tanizaki. 1973. Basophils in bronchial asthma with reference to reagin-type allergy. Clin. Allergy 3: 195-202.
39. Matute-Bello, G., G. Downey, B. B. Moore, S. D. Groshong, M. A. Matthay, A. S. Slutsky, and W. M. Kuebler; Acute Lung Injury in Animals Study Group. 2011. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 44: 725-738.
40. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 29: e45.
41. van Rijt, L. S., H. Kuipers, N. Vos, D. Hijdra, H. C. Hoogsteden, and B. N. Lambrecht. 2004. A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma. J. Immunol. Methods 288: 111-121.
42. Shirey, K. A., L. E. Cole, A. D. Keegan, and S. N. Vogel. 2008. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J. Immunol. 181: 4159-4167.
43. Corraliza, I. M., M. L. Campo, G. Soler, and M. Modolell. 1994. Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 174: 231-235.
44. Judge, A. D., M. Robbins, I. Tavakoli, J. Levi, L. Hu, A. Fronda, E. Ambegia, K. McClintock, and I. MacLachlan. 2009. Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. J. Clin. Invest. 119: 661-673.
45. Robbins, M., A. Judge, and I. MacLachlan. 2009. siRNA and innate immunity. Oligonucleotides 19: 89-102.
46. Vaporidi, K., E. Vergadi, E. Kaniaris, M. Hatziapostolou, E. Lagoudaki, D. Georgopoulos, W. M. Zapol, K. D. Bloch, and D. Iliopoulos. 2012. Pulmonary microRNA profiling in a mouse model of ventilator-induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 303: L199-L207.
47. Zhang, X., P. Shan, D. Jiang, P. W. Noble, N. G. Abraham, A. Kappas, and P. J. Lee. 2004. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J. Biol. Chem. 279: 10677-10684.
48. Alvarez, R., S. Elbashir, T. Borland, I. Toudjarska, P. Hadwiger, M. John, I. Roehl, S. S. Morskaya, R. Martinello, J. Kahn, et al. 2009. RNA interferencemediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob. Agents Chemother. 53: 3952-3962.
49. Gutbier, B., S. M. Kube, K. Reppe, A. Santel, C. Lange, J. Kaufmann, N. Suttorp, and M. Witzenrath. 2010. RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice. Pulm. Pharmacol. Ther. 23: 334-344.
50. Guo, Z., Z. Wen, A. Qin, Y. Zhou, Z. Liao, Z. Liu, Y. Liang, T. Ren, and L. Xu. 2013. Antisense oligonucleotide treatment enhances the recovery of acute lung injury through IL-10-secreting M2-like macrophage-induced expansion of CD4+ regulatory T cells. J. Immunol. 190: 4337-4348.
51. He, Z., Y. Gao, Y. Deng,W. Li, Y. Chen, S. Xing, X. Zhao, J. Ding, and X. Wang. 2012. Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway. PLoS ONE 7: e35926.
52. Takaoka, A., H. Yanai, S. Kondo, G. Duncan, H. Negishi, T. Mizutani, S. Kano, K. Honda, Y. Ohba, T. W. Mak, and T. Taniguchi. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434: 243-249.
53. Connor, A. J., J. D. Laskin, and D. L. Laskin. 2012. Ozone-induced lung injury and sterile inflammation. Role of toll-like receptor 4. Exp. Mol. Pathol. 92: 229-235.
54. Krzyzaniak, M., G. Cheadle, C. Peterson, W. Loomis, J. Putnam, P. Wolf, A. Baird, B. Eliceiri, V. Bansal, and R. Coimbra. 2011. Burn-induced acute lung injury requires a functional Toll-like receptor 4. Shock 36: 24-29.
55. Hilberath, J. N., T. Carlo, M. A. Pfeffer, R. H. Croze, F. Hastrup, and B. D. Levy. 2011. Resolution of Toll-like receptor 4-mediated acute lung injury is linked to eicosanoids and suppressor of cytokine signaling 3. FASEB J. 25: 1827-1835.
56. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
57. Ouyang, X., H. Negishi, R. Takeda, Y. Fujita, T. Taniguchi, and K. Honda. 2007. Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem. Biophys. Res. Commun. 354: 1045-1051.
58. Paun, A., R. Bankoti, T. Joshi, P. M. Pitha, and S. Stäger. 2011. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. PLoS Pathog. 7: e1001246.
59. Krausgruber, T., K. Blazek, T. Smallie, S. Alzabin, H. Lockstone, N. Sahgal, T. Hussell, M. Feldmann, and I. A. Udalova. 2011. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12: 231-238.
60. Lawrence, T., and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11: 750-761.
61. Nahid, M. A., K. M. Pauley, M. Satoh, and E. K. Chan. 2009. miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J. Biol. Chem. 284: 34590-34599.
62. Hou, J., P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang, and X. Cao. 2009. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183: 2150-2158.
63. Tang, Y., X. Luo, H. Cui, X. Ni, M. Yuan, Y. Guo, X. Huang, H. Zhou, N. de Vries, P. P. Tak, et al. 2009. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60: 1065-1075.
64. O'Connell, R. M., D. S. Rao, and D. Baltimore. 2012. microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30: 295-312.